Endovia Health Sciences EDVA
NYSE EDVA
$0.27 +0.01 (+2.57%)
As of: Sep 3, 2026 · 12:48 PM EDT

Endovia Health Sciences (EDVA) Sales of Property, Plant and Equipment (2016 - 2019)

Analysis

Endovia Health Sciences (EDVA) Sales of Property, Plant and Equipment (2016 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 141.06 Bn 133.21 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.96 Bn 78.97 Bn 3.93 Bn -
3 Argenx Se 64.93 Bn 59.74 Bn 1.37 Bn -
4 Moderna 57.22 Bn 52.08 Bn 52.00 Mn -
5 Revolution Medicines 44.59 Bn 44.59 Bn - -
6 BeOne Medicines 40.43 Bn 35.33 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.17 Bn 27.34 Bn - -
9 Insmed 27.60 Bn 26.43 Bn 358.27 Mn -
10 Endovia Health Sciences 821,701.01 578,999.01 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 3,908.00
Sep 30, 2019 832.00
Jun 30, 2019 948.00
Mar 31, 2019 758.00
Dec 31, 2018 705.00
Sep 30, 2018 885.00
Jun 30, 2018 1,085.00
Mar 31, 2018 5,389.00
Dec 31, 2017 5,757.00
Sep 30, 2017 4,072.00
Jun 30, 2017 3,047.00
Mar 31, 2017 3,171.00
Dec 31, 2016 1,390.00
Sep 30, 2016 1,912.00
Jun 30, 2016 1,635.00
Mar 31, 2016 1,411.00